RevOpsis Therapeutics

Springfield, United States

RevOpsis Therapeutics employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.

Sep 2025

Seed

Health Care Life Science Medical

Top Investors

ExSight Ventures National Eye Institute

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about RevOpsis Therapeutics

Who are RevOpsis Therapeutics's investors?

RevOpsis Therapeutics's investors include ExSight Ventures, National Eye Institute.

Where is RevOpsis Therapeutics headquartered?

RevOpsis Therapeutics is headquartered in Springfield, United States.

What does RevOpsis Therapeutics do?

RevOpsis Therapeutics employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.

What stage is RevOpsis Therapeutics at?

RevOpsis Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 16, 2025.

MLA

"RevOpsis Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/revopsis-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). RevOpsis Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/revopsis-therapeutics

Wikipedia (cite web)

{{cite web |title=RevOpsis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/revopsis-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 16, 2025.